Chronic obstructive pulmonary disease (COPD) is a major and increasing global health
problem that is now a leading cause of death. COPD is associated with a chronic …

Chronic obstructive pulmonary diseases (COPD), comprised of pulmonary emphysema,
chronic bronchitis, and structural and inflammatory changes of small airways, is a leading …

Anticholinergics are widely used for the treatment of COPD, and to a lesser extent for
asthma. Primarily used as bronchodilators, they reverse the action of vagally derived …

Cytokines play an important part in many pathobiological processes of chronic obstructive
pulmonary disease (COPD), including the chronic inflammatory process, emphysema, and …

Despite widespread expression of epidermal growth factor (EGF) receptors (EGFRs) and
EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase …

Chronic obstructive pulmonary disease (COPD) is a major disease of the lungs. It primarily
occurs after a prolonged period of cigarette smoking. Chronic inflammation of airways and …

No currently available treatments have been shown to slow the progression of chronic
obstructive pulmonary disease (COPD) or suppress the inflammation in small airways and …

The pathogenesis of chronic obstructive pulmonary disease (COPD) encompasses a
number of injurious processes, including an abnormal inflammatory response in the lungs to …

Background: Ongoing inflammatory processes resulting in airway and vascular remodelling
characterise chronic obstructive pulmonary disease (COPD). Vascular endothelial growth …

Idiopathic pulmonary fibrosis (IPF) is characterized by progressive fibroblast and
myofibroblast proliferation, and extensive deposition of extracellular matrix (ECM). Fibroblast …